Defining antimicrobial resistance in cystic fibrosis

Affiliations

¹ School of Chemistry and Molecular Biosciences, The University of Queensland, Lung Bacteria Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Electronic address: t.m.kidd@uq.edu.au.
² Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. Electronic address: Rafael.canton@salud.madrid.org.
³ Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: M.Ekkelenkamp@umcutrecht.nl.
⁴ Department of Clinical Microbiology, Rigshospitalet, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: hkj@biosustain.dtu.dk.
⁵ Clinical Microbiology-Immunology Laboratories, UNC HealthCare, Chapel Hill, NC, USA. Electronic address: peter.gilligan@unchealth.unc.edu.
⁶ Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: jlipuma@med.umich.edu.
⁷ Department of Thoracic Medicine, The Prince Charles Hospital and QIMR Berghofer Medical Researhc Institute, Brisbane, Australia. Electronic address: scott.bell@health.qld.gov.au.
⁸ Imperial College and Royal Brompton Hospital, London, Queen's University Belfast, United Kingdom. Electronic address: j.elborn@inperial.ac.uk.
⁹ Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, SC, USA. Electronic address: flumepa@musc.edu.
¹⁰ Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: drv15@case.edu.
¹¹ Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, USA. Electronic address: Valerie.waters@sickkids.ca.

PMID: 30266518
DOI: 10.1016/j.jcf.2018.08.014

Free article

Review

Defining antimicrobial resistance in cystic fibrosis

Timothy J Kidd et al. J Cyst Fibros. 2018 Nov.

Free article

. 2018 Nov;17(6):696-704.

doi: 10.1016/j.jcf.2018.08.014. Epub 2018 Sep 25.

Affiliations

¹ School of Chemistry and Molecular Biosciences, The University of Queensland, Lung Bacteria Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Electronic address: t.m.kidd@uq.edu.au.
² Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. Electronic address: Rafael.canton@salud.madrid.org.
³ Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: M.Ekkelenkamp@umcutrecht.nl.
⁴ Department of Clinical Microbiology, Rigshospitalet, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: hkj@biosustain.dtu.dk.
⁵ Clinical Microbiology-Immunology Laboratories, UNC HealthCare, Chapel Hill, NC, USA. Electronic address: peter.gilligan@unchealth.unc.edu.
⁶ Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: jlipuma@med.umich.edu.
⁷ Department of Thoracic Medicine, The Prince Charles Hospital and QIMR Berghofer Medical Researhc Institute, Brisbane, Australia. Electronic address: scott.bell@health.qld.gov.au.
⁸ Imperial College and Royal Brompton Hospital, London, Queen's University Belfast, United Kingdom. Electronic address: j.elborn@inperial.ac.uk.
⁹ Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, SC, USA. Electronic address: flumepa@musc.edu.
¹⁰ Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: drv15@case.edu.
¹¹ Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, USA. Electronic address: Valerie.waters@sickkids.ca.

PMID: 30266518
DOI: 10.1016/j.jcf.2018.08.014

Abstract

Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Defining antimicrobial resistance in cystic fibrosis

Affiliations

Defining antimicrobial resistance in cystic fibrosis

Authors

Affiliations

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical